Brief: Camurus' CAM2029 Achieves Superior Treatment Response Compared To Placebo In Phase 3 Acromegaly Trial

Camurus AB

20/06/2023 06:35

June 20 (Reuters) - Camurus AB  CAMX.ST :
    * CAMURUS' OCTREOTIDE SC DEPOT (CAM2029) ACHIEVES SUPERIOR
TREATMENT RESPONSE COMPARED TO PLACEBO IN PHASE 3 ACROMEGALY
TRIAL
    * PRIMARY AND KEY SECONDARY ENDPOINTS MET FOR ONCE MONTHLY
OCTREOTIDE SC DEPOT
    * DATA SHOW IMPROVEMENT IN QUALITY OF LIFE VERSUS STANDARD
OF CARE
AT BASELINE
    * WELL TOLERATED SAFETY PROFILE WITH NO NEW OR UNEXPECTED
FINDINGS

Source text for Eikon:  ID:nWkr6SY3Zg 
Further company coverage:  CAMX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))